TABLE 1.
Baseline patient characteristics (n = 30)
| Characteristic | Value |
|---|---|
| Age (years) | |
| Median (range) | 32 (19–65) |
| Gender, n (%) | |
| Female | 10 (33) |
| Male | 20 (67) |
| Race, n (%) | |
| White | 28 (93) |
| Asian | 1 (3) |
| Unknown | 1 (3) |
| WHO performance status, n (%) | |
| 0 | 16 (53) |
| 1 | 13 (43) |
| 2 | 1 (3) |
| Primary tumor location, n (%) | |
| Abdomen | 1 (3) |
| Cervix | 1 (3) |
| Extremity | 9 (30) |
| Kidney | 1 (3) |
| Lung | 3 (10) |
| Other | 4 (13) |
| Ovary | 1 (3) |
| Pelvis | 5 (17) |
| Peritoneum | 1 (3) |
| Spinal cord | 1 (3) |
| Spine | 2 (7) |
| Uterus | 1 (3) |
| Primary site type, n (%) | |
| Bone | 12 (40) |
| Extraskeletal | 18 (60) |
| Number of prior lines of systemic therapy, n (%) | |
| 1 | 5 (17) |
| 2 | 10 (33) |
| 3 | 5 (17) |
| 4 | 4 (13) |
| ≥5 | 6 (20) |
| Months from diagnosis to start of trial | |
| Median, range | 42, 1–233 |